The breast cancer susceptibility allele CHEK2*1100delC promotes genomic instability in a knock-in mouse model

被引:17
作者
Bahassi, El Mustapha
Penner, C. Gail
Robbins, Susan B.
Tichy, Elisia
Feliciano, Estrella
Yin, Moying
Liang, Li
Deng, Li
Tischfield, Jay A.
Stambrook, Peter J.
机构
[1] Univ Cincinnati, Coll Med, Dept Cell & Canc Biol Neurobiol & Anat, Cincinnati, OH 45267 USA
[2] Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA
关键词
CHEK2; breast cancer; DNA damage; mouse model; genomic instability;
D O I
10.1016/j.mrfmmm.2006.11.025
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Allelic variants of CHEK2 contribute to an elevated risk for human breast cancer and possibly other cancer types. In particular, the CHEK2*1100delC polymorphic variant has been identified as a low-penetrance breast cancer susceptibility allele in breast cancer families with wild type BRCA1 and BRCA2. To better understand the molecular basis by which this allele increases risk for disease, we have generated a mouse in which the wild type CHEK2 (Chk2 in mouse) allele has been replaced with the 1100delC variant. Mouse embryo fibroblasts (MEFs) derived from these mice have an altered cell cycle profile in which a far greater proportion of cells are in S-phase and in G2 (4N) compared with wild type cells. The mutant cells show signs of spontaneous genomic instability as indicated by polyploidy and an increase in DNA double strand breaks. (c) 2006 Published by Elsevier B.V.
引用
收藏
页码:201 / 209
页数:9
相关论文
共 45 条
[1]   The Chk2 protein kinase [J].
Ahn, J ;
Urist, M ;
Prives, C .
DNA REPAIR, 2004, 3 (8-9) :1039-1047
[2]  
Ahn JY, 2000, CANCER RES, V60, P5934
[3]   Mutation analysis of the CHK2 gene in families with hereditary breast cancer [J].
Allinen, M ;
Huusko, P ;
Mäntyniemi, S ;
Launonen, V ;
Winqvist, R .
BRITISH JOURNAL OF CANCER, 2001, 85 (02) :209-212
[4]  
BAHASSI DL, 2006, MUTAT RES, V596, P166
[5]   DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation [J].
Bakkenist, CJ ;
Kastan, MB .
NATURE, 2003, 421 (6922) :499-506
[6]   Analysis of CHEK2 gene for ovarian cancer susceptibility [J].
Baysal, BE ;
DeLoia, JA ;
Willett-Brozick, JE ;
Goodman, MT ;
Brady, MF ;
Modugno, F ;
Lynch, HT ;
Conley, YP ;
Watson, P ;
Gallion, HH .
GYNECOLOGIC ONCOLOGY, 2004, 95 (01) :62-69
[7]   Excess risk for contralateral breast cancer in CHEK2*1100delC germline mutation carriers [J].
Broeks, A ;
de Witte, L ;
Nooijen, A ;
Huseinovic, A ;
Klijn, JGM ;
van Leeuwen, FE ;
Russell, NS ;
van't Veer, LJ .
BREAST CANCER RESEARCH AND TREATMENT, 2004, 83 (01) :91-93
[8]   The CHEK2 c.1100delC mutation plays an irrelevant role in breast cancer predisposition in Italy [J].
Caligo, MA ;
Agata, S ;
Aceto, G ;
Crucianelli, R ;
Manoukian, S ;
Peissel, B ;
Scaini, MC ;
Sensi, E ;
Veschi, S ;
Cama, A ;
Radice, P ;
Viel, A ;
D'Andrea, E ;
Montagna, M .
HUMAN MUTATION, 2004, 24 (01) :100-101
[9]   Embryonic stem cells and somatic cells differ in mutation frequency and type [J].
Cervantes, RB ;
Stringer, JR ;
Shao, CS ;
Tischfield, JA ;
Stambrook, PJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (06) :3586-3590
[10]  
Chehab NH, 2000, GENE DEV, V14, P278